Scout | PAR-24-099: SBIR Phase II (U44) funding to implement small business–led clinical trials in NIAID priority areas

This opportunity is no longer accepting applications.

grant PAR-24-099

SBIR Phase II (U44) funding to implement small business–led clinical trials in NIAID priority areas

Summary

NIAID invites SBIR Phase II (U44) applications from small businesses to run hypothesis- and milestone-driven clinical trials aligned with its infectious, immunologic, and allergic disease mission. High-risk trials and embedded mechanistic studies are encouraged; applicants must propose only one trial, have planning completed by submission, and be ready to launch at award. This cooperative agre…

This Notice of Funding Opportunity (NOFO) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials.

This progr…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Institute of Allergy and Infectious Diseases

Phase: Phase II

Awards & funding

Award Ceiling: $1M

Eligibility

For-Profit Organizations: United States Small Business Concerns (SBCs)

Joint ventures that qualify as U.S. SBCs (each party must meet SBIR ownership/control rules; JV must have <50% participation by foreign business entities)

SBCs more than 50% directly owned and controlled by U.S. citizens or permanent resident aliens (including through other qualifying U.S.-owned business concerns)

SBCs owned by an Indian Tribe, Alaska Native Corporation (ANC), or Native Hawaiian Organization (NHO), or a wholly owned business entity of such tribe/ANC/NHO

SBIR-only: SBCs more than 50% owned by multiple venture capital operating companies (VCOCs), hedge funds, private equity firms, or any combination (no single firm may own >50% unless that firm itself qualifies as a U.S.-owned SBC)

Only United States small business concerns (SBCs) are eligible to apply.

Core SBC eligibility (must be met at time of Phase I and Phase II award):

Organized for profit with a place of business in the United States; operates primarily in the U.S. or makes a significant contrib…

Dates

Opportunity Released: January 29, 2024

Open for Submission: January 29, 2024

Submission Deadline: January 13, 2027

Application Window Closes: January 13, 2027

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers